Introduction
Medicare
Reports
Displaying 1 - 10 of 176. 10 per page. Page 1.
Advanced SearchReport
The Inflation Reduction Act of 2022: One Year Anniversary Highlights from ASPE Drug Pricing Reports
August 16, 2023
Ownership of Hospitals: An Analysis of Newly-Released Federal Data & A Method for Assessing Common Owners
August 7, 2023
To enhance transparency in health care markets, in December 2022, the Centers for Medicare & Medicaid Services (CMS) publicly released comprehensive data on the ownership of all U.S. hospitals that are enrolled in Medicare. This report provides an overview of the available data, a methodology for assigning hospitals to chains, and several preliminary analyses to showcase the data.
Report
Updated Medicare FFS Telehealth Trends by Beneficiary Characteristics, Visit Specialty and State, 2019-2021
July 20, 2023
This research report updates prior reports on Medicare FFS telehealth trends during the COVID-19 public health emergency with data through end of 2021, by beneficiary characteristics, visit specialty and geography including by state. Medicare telehealth flexibilities during the COVID-19 pandemic continued to encourage use of telehealth among Medicare beneficiaries in 2021.
ASPE Issue Brief
Medicare Advantage Overview: A Primer on Enrollment and Spending
May 25, 2023
Enrollment in Medicare Advantage plans has increased rapidly in recent years. The share of eligible Medicare beneficiaries enrolled in MA rose from 25% in 2010 to 47% in 2021 (27.6 million enrollees). Payments to MA plans more than doubled between 2015 and 2021 (from $175 to $361 billion), taking the share of total Medicare Parts A & B spending on MA from 38% to 54%.
Report
Understanding Coverage Considerations for COVID-19 Vaccines and Treatments
May 8, 2023
Understanding Coverage Considerations for COVID-19 Vaccines and Treatments (Updated May 2023)
ASPE Data Point
Insulin Affordability and the Inflation Reduction Act: Medicare Beneficiary Savings by State and Demographics
January 24, 2023
Effective January 1, 2023, out-of-pocket costs for insulin are capped at $35 per monthly prescription among Medicare Part D enrollees under the Inflation Reduction Act (IRA). A similar cap takes effect in Medicare Part B on July 1, 2023.
Report to Congress
Report to Congress on the Affordability of Insulin
December 16, 2022
This Report to Congress examines the critical role that insulin plays in the treatment of diabetes, reviews evidence on how insulin affordability affects adherence to insulin treatment and affects downstream health consequences, and describes policy efforts to improve the affordability of insulin.
ASPE Issue Brief
Ownership of Skilled Nursing Facilities: An Analysis of Newly-Released Federal Data
December 15, 2022
To enhance transparency in health care markets, in September 2022, the Centers for Medicare & Medicaid Services (CMS) publicly released comprehensive data on the ownership of all U.S. skilled nursing facilities (SNFs) that are enrolled in Medicare. This report provides an overview of the available data, a methodology for calculating the ownership shares by individuals vs.
ASPE Issue Brief
State Medicaid Telehealth Policies Before and During the COVID-19 Public Health Emergency: 2022 Update
November 22, 2022
This issue brief provides updates on state Medicaid policies regarding delivery of telehealth services by provider types and modalities, as of January 2022. The COVID-19 pandemic substantially accelerated interest in and utilization of telehealth across all payers including Medicaid.
Report
Medicare Data Linkages for Conducting Patient-Centered Outcomes Research on Economic Outcomes
October 13, 2022
This report and dataset inventory identifies federally funded data linkages that may facilitate patient-centered outcomes research (PCOR) on economic outcomes for Medicare fee-for-service (FFS) beneficiaries.